INDRAPRASTHA MEDICAL CORPORATION
Back to Cashflow Statement
|
INDRAPRASTHA MEDICAL CORPORATION Last 5 Year Cash Flow from Financing Activities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Financing Activities | ₹-32 Cr | ₹-26 Cr | ₹-3.37 Cr | ₹-3.14 Cr | ₹-43 Cr |
What is the latest Cash Flow from Financing Activities ratio of INDRAPRASTHA MEDICAL CORPORATION ?
Year | Cash Flow from Financing Activities |
---|---|
Mar2024 | ₹-32 Cr |
Mar2023 | ₹-26 Cr |
Mar2022 | ₹-3.37 Cr |
Mar2021 | ₹-3.14 Cr |
Mar2020 | ₹-43 Cr |
How is Cash Flow from Financing Activities of INDRAPRASTHA MEDICAL CORPORATION Trending?
Years | Cash Flow from Financing Activities | % Change | |
---|---|---|---|
Mar2024 | ₹-32 Cr | Negative | |
Mar2023 | ₹-26 Cr | Negative | |
Mar2022 | ₹-3.37 Cr | Negative | |
Mar2021 | ₹-3.14 Cr | Negative | |
Mar2020 | ₹-43 Cr | - |
Compare Cash Flow from Financing Activities of peers of INDRAPRASTHA MEDICAL CORPORATION
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
INDRAPRASTHA MEDICAL CORPORATION | ₹4,281.0 Cr | 11.6% | 6.8% | 144.8% | Stock Analytics | |
APOLLO HOSPITALS ENTERPRISE | ₹106,701.0 Cr | 6.7% | 6.7% | 44.5% | Stock Analytics | |
MAX HEALTHCARE INSTITUTE | ₹104,835.0 Cr | 4% | 13.3% | 80.2% | Stock Analytics | |
FORTIS HEALTHCARE | ₹46,875.4 Cr | -2.2% | 1.1% | 84.8% | Stock Analytics | |
GLOBAL HEALTH | ₹28,676.8 Cr | -0.2% | 2.8% | 30.7% | Stock Analytics | |
NARAYANA HRUDAYALAYA | ₹26,368.7 Cr | 6.5% | 5.5% | 17.2% | Stock Analytics |
INDRAPRASTHA MEDICAL CORPORATION Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
INDRAPRASTHA MEDICAL CORPORATION | 11.6% |
6.8% |
144.8% |
SENSEX | -0.3% |
-2.4% |
22.4% |
You may also like the below Video Courses